Polyclonal Anti-FGFR1 Antibody

fibroblast growth factor receptor 1
Recommended Applications
Product Description
Polyclonal Antibody against Human FGFR1
Alternative Gene Names
BFGFR, CD331, CEK, FLG, FLT2, H2, H3, H4, H5, KAL2, N-SAM
Product Number
Unit Size
Lot dependent
6 in Stock
Ready to Ship
Target Protein
fibroblast growth factor receptor 1
Target Gene
Antigen Sequence
Recombinant Protein Epitope Signature Tag (PrEST) antigen sequence
Verified Species Reactivity
Interspecies Information

Highest antigen sequence identity to the following orthologs:

Rat ENSRNOG00000016050 (96%)

Mouse ENSMUSG00000031565 (94%)

40% glycerol and PBS (pH 7.2). 0.02% sodium azide is added as preservative. Material Safety Data Sheet
Purification Method
Affinity purified using the PrEST antigen as affinity ligand
Gently mix before use. Optimal concentrations and conditions for each application should be determined by the user.
Unit Size
100 µl
Current Lot
Produced on demand. Contact support@atlasantibodies.com for more information.
Product Data Sheet
Immunohistochemistry (IHC)

Recommended conditions:

Dilution: 1:50 - 1:200

Retrieval method: HIER pH6

Western Blot (WB)

Recommended conditions:

Working concentration: 0.04-0.4 µg/ml

Western Blot (WB)

Validated in Western blot using relevant lysates (see Western blot application images above)

Protein Name
fibroblast growth factor receptor 1
Gene Name
Alternative Gene Names
BFGFR, CD331, CEK, FLG, FLT2, H2, H3, H4, H5, KAL2, N-SAM
UniProt ID
Gene (Ensembl)
Entrez Gene ID
Normally shipped at ambient temperature
Store at +4°C for short term storage. Long time storage is recommended at -20°C.
Human Protein Atlas

This antibody has been used for staining of 44 normal human tissue samples as well as human cancer samples covering the 20 most common cancer types and up to 12 patients for each cancer type. The results are part of an ongoing effort to map the human proteome using antibodies.

All characterization data for ENSG00000077782 on the Human Protein Atlas

Akhand SS, Chen H, Purdy SC, Liu Z, Anderson JC, Willey CD, Wendt MK

Fibroblast growth factor receptor facilitates recurrence of minimal residual disease following trastuzumab emtansine therapy

NPJ Breast Cancer , 2021 Jan 21; 7:5. Epub 2021 Jan 21

PubMed ID: 33479246 DOI: 10.1038/s41523-020-00213-5

Did we miss your publication?

Have you published using HPA056402? Please let us know and we will be happy to include your reference on this page.

Read more

Join the Explorer Program

Are you using our products in an application or species we have not yet tested? Why not participate in the Explorer Program, and we will show your contribution here. If you would like to share your results with us, the Explorer Program offers a 25µl vial free of charge with your next order.

Read more

Alternative Antibodies
Corresponding Antigens


Our customer support and expert scientific support teams are here to help you succeed in your research.

Get in touch